US President Donald Trump on August 23 announced that the Food and Drug Administration (FDA) has authorized the use of convalescent plasma to treat COVID-19 patients.
He said, "Today I am pleased to make a truly historic announcement, in our battle against China virus, that will save countless lives.
The FDA (Food and Drug Administration) has issued an emergency use authorisation for a treatment known as convalescent plasma."
